Literature DB >> 17128683

Management and in-hospital outcome of patients with first episode of acute myocardial infarction: impact of diabetes mellitus.

Aysegul Atmaca1, Serkan Dogan, Selcuk Dagdelen, Giray Kabakci, Sirri Kes, Nasih Nazli, Tomris Erbas.   

Abstract

The aim of this study is to compare clinical characteristics, management, complications, in-hospital outcome and mortality of diabetic and nondiabetic patients after the first episode of acute myocardial infarction (MI). This retrospective case-matched study included 60 diabetic and 55 non-diabetic patients. Medical information about patients was retrieved from the hospital recordings. Diabetic patients were older, were more hypertensive and had more coronary artery disease history than nondiabetic patients. The frequency of use of acute reperfusion therapy modalities was not statistically different between the two groups. Diabetes was a significant determinant against the use of beta blockers (OR=0.26; 95% CI 0.06-0.95) but in favor of angiotensin converting enzyme inhibitors (OR=3.3; 95% CI 1.17-9.36), whereas diabetes did not influence the use of other drugs. Diabetic patients had more complications than nondiabetic patients (40.0% and 16.3%, respectively, p=0.005). In-hospital mortality rate for diabetic patients was comparable to nondiabetic patients (16.7% and 10.9%, respectively, p=0.373). Pharmaceutical treatment regimens, particularly beta blockers, are underutilized after acute MI in diabetic patients. More frequent use of these regimens will improve the high complication and mortality rates in diabetic patients as well as in nondiabetic patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17128683      PMCID: PMC2569786     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  26 in total

1.  1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Authors:  T J Ryan; E M Antman; N H Brooks; R M Califf; L D Hillis; L F Hiratzka; E Rapaport; B Riegel; R O Russell; E E Smith; W D Weaver; R J Gibbons; J S Alpert; K A Eagle; T J Gardner; A Garson; G Gregoratos; S C Smith
Journal:  Circulation       Date:  1999-08-31       Impact factor: 29.690

2.  Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators.

Authors:  D K McGuire; H Emanuelsson; C B Granger; E Magnus Ohman; D J Moliterno; H D White; D Ardissino; J W Box; R M Califf; E J Topol
Journal:  Eur Heart J       Date:  2000-11       Impact factor: 29.983

3.  [Current prescription practice of CSE inhibitors at clinic discharge after acute myocardial infarct].

Authors:  H Wienbergen; R Schiele; A K Gitt; S Schneider; T Heer; H Gohlke; M Gottwik; R Thiele; M Keysser; A Horsch; A Weizel; J Senges
Journal:  Z Kardiol       Date:  2001-06

4.  [Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries].

Authors:  B Frilling; R Schiele; R Zahn; F Fischer; S Schneider; A K Gitt; T Heer; M Gottwik; H G Glunz; U Gieseler; B Baumgärtel; F Asbeck; J Senges
Journal:  Z Kardiol       Date:  2002-02

5.  Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?

Authors:  Li Wei; Robert Flynn; Gordon D Murray; Thomas M MacDonald
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-11       Impact factor: 2.890

6.  Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.

Authors:  Anna Norhammar; Klas Malmberg; Lars Rydén; Per Tornvall; Ulf Stenestrand; Lars Wallentin
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

7.  Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.

Authors:  C B Granger; R M Califf; S Young; R Candela; J Samaha; S Worley; D J Kereiakes; E J Topol
Journal:  J Am Coll Cardiol       Date:  1993-03-15       Impact factor: 24.094

8.  Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

9.  Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.

Authors:  Birgit Frilling; Rudolf Schiele; Anselm Kai Gitt; Ralf Zahn; Steffen Schneider; Hans-Georg Glunz; Ulf Gieseler; Edwin Jagodzinski; Jochen Senges
Journal:  Am Heart J       Date:  2004-08       Impact factor: 4.749

10.  Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study.

Authors:  A K Gitt; R Schiele; H Wienbergen; U Zeymer; S Schneider; M G Gottwik; J Senges
Journal:  Acta Diabetol       Date:  2003-12       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.